deoxypyridinoline has been researched along with bay 12-9566 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arima, N; Hamada, T; Sasaguri, Y; Shindo, M; Sugama, K | 1 |
| Adjei, AA; Alberts, SR; Atherton, PJ; Erlichman, C; Goldberg, RM; Humphrey, R; Klee, GG; Pitot, HC; Rubin, J; Sloan, JA | 1 |
1 trial(s) available for deoxypyridinoline and bay 12-9566
| Article | Year |
|---|---|
Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.
Topics: Adult; Amino Acids; Antineoplastic Agents; Biphenyl Compounds; Dose-Response Relationship, Drug; Endothelial Growth Factors; Enzyme Inhibitors; Female; Fibroblast Growth Factor 2; Humans; Lymphokines; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Maximum Tolerated Dose; Middle Aged; Neoplasms; Organic Chemicals; Phenylbutyrates; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
1 other study(ies) available for deoxypyridinoline and bay 12-9566
| Article | Year |
|---|---|
Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase-inhibitor.
Topics: Amino Acids; Animals; Antineoplastic Agents; Arthritis, Experimental; Biphenyl Compounds; Body Weight; Edema; Hindlimb; Indomethacin; Inflammation; Male; Matrix Metalloproteinase Inhibitors; Organic Chemicals; Phenylbutyrates; Rats; Rats, Sprague-Dawley; Weight Gain | 2000 |